Anti-SND1 antibody [EPR28903-23],Abcam,AB322053
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human, Mouse, Rat
Application
WB, IHC-P, I-ELISA
Platform ID
BAB788921809
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Specifications
Scientific Background
Target data Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs (PubMed : 18453631, PubMed : 28546213). As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition (PubMed : 28546213). Functions as a bridging factor between STAT6 and the basal transcription factor (PubMed : 12234934). Plays a role in PIM1 regulation of MYB activity (PubMed : 9809063). Functions as a transcriptional coactivator for STAT5 (By similarity).. (Microbial infection) Functions as a transcriptional coactivator for the Epstein-Barr virus nuclear antigen 2 (EBNA2).. (Microbial infection) Promotes SARS-CoV-2 RNA synthesis by binding to negative-sense RNA and the viral protein nsp9. See full target information SND1
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Please provide the required information below so that we can quickly source your products.